Symptoma
PrivateLast Round
Grant
Apr 1, 2021
Total Funding Raised
$2.01M
Company Overview
Symptoma operates in Healthcare & Life Sciences and is based in Vienna. Its latest recorded funding round was a Grant round in April 2021.
Symptoma is a healthtech company that has developed a medical search engine designed to offer an online diagnosis of diseases and help patients and physicians find possible medical causes for their symptoms.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, NLP & Conversational AI, Medical Devices, Healthcare Analytics, InsurTech
Business Model
B2B
Customer Profile
Subscription SaaS, Freemium, Government Contracts, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Symptoma Comparables
Compare Symptoma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mediktor | 83% | |
| Isabel Healthcare | 83% | |
| Healthily | 81% |
For institutional investors. Book with your work email.
Symptoma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 1, 2021 | ||||
| Grant | Sep 1, 2018 |
For institutional investors. Book with your work email.
Symptoma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| COVID-X | Grant |
| European Commission | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 19, 2026
Grew 133% QoQ, from 3 to 7 employees.
- Jul 2, 2025
Monthly visitors grew 48% MoM, reaching 21.4K.
For institutional investors. Book with your work email.
Symptoma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Symptoma's valuation, stock price, and market status.
Is Symptoma a public or private company?
Symptoma is a private company.
What is the current stock price of Symptoma?
Symptoma is a private company, so its shares have no public market price. Caplight tracks Symptoma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Symptoma worth (valuation)?
Valuation information for Symptoma is not publicly available.
Can I buy Symptoma stock?
Symptoma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Symptoma's last funding round?
Symptoma's most recent funding round was Grant on April 1, 2021.
Who are the main investors in Symptoma?
Key investors in Symptoma include European Union's Horizon Research and Innovation program, COVID-X, European Commission.
Will Symptoma IPO soon?
No public IPO plans have been announced for Symptoma.
How can I track Symptoma secondary market activity?
Caplight tracks bids, offers, and trades in Symptoma's shares on secondary markets.